PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. has strategic partnership with Benuvia Operations, LLC to manufacture cGMP pharmaceutical-grade CBD isolate and related products. PharmaCielo Ltd. is headquartered in Toronto, Canada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.06222130319057001 | N/A |
Market Cap | $10.26M | N/A |
Shares Outstanding | 164.96M | N/A |
Employees | 0 | N/A |